Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Advanced Biomedical Research and Innovation
betkolik betlike betpark betticket betturkey extrabet holiganbet ilbet ikimisli imajbet jojobet kralbet mariobet marsbahis meritking milanobet piabet redwin süpertotobet tempobet
Irlene Shen Author
Subjects of specialization
Affiliation
Applied Microbiology, Applied Microscopy, Applied Mycology, Applied Physiology, Biomedical Research
MSc Health Economics at the University of York. She received her MSc in Clinical Drug Development at Queen Mary, University of London
Biography
Irlene Shen is currently studying MSc Health Economics at the University of York. She received her MSc in Clinical Drug Development at Queen Mary, University of London in 2013. She worked as a clinical pharmacist in the hospital in Taiwan and specialized in Asthma, Diabetes Mellitus and Cardiovascular diseases.
Publications
Short Communication Open Access
Biotech/pharma companies will be healthcare solution providers
Author(s): Irlene Shen
Pharma companies will focus on newer approach such as technology to effectively develop products and make products appealing more to providers and payers, end users. The way forward will mean selling a total experience, not just a product. To realize total experience, drug-mobile-database digital therapeutics (DTx) as the solutions for the affected stakeholders and users.
Digital therapeutics (DTx) come in varieties and utilize, each may offer different strategies, meaningful incentives particularly smartphones and wearables, products include game-play elements to treat mental- and behavioral issues, helped improve motivation, engagement, and outcomes in treating arthritis, diabetes, back pain, obesity, and mental health problems (e.g. anxiety, depression), neurological disord... view more»
Social Media
Google Scholars / Researchers Sites
